Get in touch
555-555-5555
mymail@mailservice.com
ABOUT US
OUR MISSION
To drive and implement medical advances which will allow heart transplant patients to live their lives to the fullest.
WHY WE DO IT
Heart transplants are often the only available treatment for patients with end-stage heart failure, with more than 8000 taking place every year worldwide. Though the short-term success rate of heart transplants is now high, long term clinical outcome remains unacceptable, with the majority of allografts surviving approximately 10 years.
HOW WE DO IT
We have identified the following three streams to improve quality of life for heart transplant patients:
- 3D Bioprinting the world’s first transplantable human heart
- Using T Cell Therapy to achieve allograft tolerance
- Early modelling and detection of rejection
WHO WE ARE
Santorini Scientific is led by Mike Adams, an entrepreneur and visionary with over 35 years of experience in research and new technologies, including considerable depth of expertise in the pharmaceutical and hospital sectors. He has worked with organisations including Spire Health Care, Hertfordshire Health Authority, Pfizer, Uni-Chem and Medicare.
Cardiac bioprinting for transplant purposes requires an interdisciplinary team with expertise in a variety of different fields. Santorini Scientific is working to overcome the challenge of ensuring knowledge is shared between disciplines, in order to achieve its ambitious goal of 3D bioprinting the world’s first transplantable human heart, which can only be accomplished through collaboration.
The Technical Steering Group includes luminaries with specific expertise:
- John Jeans CBE, Chairman at the Digital Health and Care Institute
- Geraint Thomas, Professor of Biochemistry at University College London.
- Professor Kenneth Dalgarno, Professor of Manufacturing Engineering at Newcastle University
- Geoff McFarland, specialist in the application of 3D technology in the field of additive manufacturing and medicine
- Rob Hemsley, Chief Financial Officer at Matter.; Chief Financial Officer at Inheriting Earth
Find out more about them on our Partners Page.